In conclusion, the advancements in research on the glycolytic pathway and the glycolysis-related gene PGK1 in the context of breast cancer under hypoxic conditions offer valuable insights into the mechanisms and therapeutic targets of metabolic reprogramming in breast cancer. The gene discussed is PGK1; the disease is breast cancer.